471 related articles for article (PubMed ID: 22831748)
21. New ABCC8 mutations in relapsing neonatal diabetes and clinical features.
Vaxillaire M; Dechaume A; Busiah K; Cavé H; Pereira S; Scharfmann R; de Nanclares GP; Castano L; Froguel P; Polak M;
Diabetes; 2007 Jun; 56(6):1737-41. PubMed ID: 17389331
[TBL] [Abstract][Full Text] [Related]
22. Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.
Girard CA; Shimomura K; Proks P; Absalom N; Castano L; Perez de Nanclares G; Ashcroft FM
Pflugers Arch; 2006 Dec; 453(3):323-32. PubMed ID: 17021801
[TBL] [Abstract][Full Text] [Related]
23. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.
Masia R; Koster JC; Tumini S; Chiarelli F; Colombo C; Nichols CG; Barbetti F
Diabetes; 2007 Feb; 56(2):328-36. PubMed ID: 17259376
[TBL] [Abstract][Full Text] [Related]
24. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.
Flechtner I; de Lonlay P; Polak M
Diabetes Metab; 2006 Dec; 32(6):569-80. PubMed ID: 17296510
[TBL] [Abstract][Full Text] [Related]
25. Mutations in the ABCC8 gene encoding the SUR1 subunit of the KATP channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal period.
Patch AM; Flanagan SE; Boustred C; Hattersley AT; Ellard S
Diabetes Obes Metab; 2007 Nov; 9 Suppl 2(Suppl 2):28-39. PubMed ID: 17919176
[TBL] [Abstract][Full Text] [Related]
26. The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy.
Sandal T; Laborie LB; Brusgaard K; Eide SA; Christesen HB; Søvik O; Njølstad PR; Molven A
Clin Genet; 2009 May; 75(5):440-8. PubMed ID: 19475716
[TBL] [Abstract][Full Text] [Related]
27. Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation.
Zwaveling-Soonawala N; Hagebeuk EE; Slingerland AS; Ris-Stalpers C; Vulsma T; van Trotsenburg AS
Diabetologia; 2011 Feb; 54(2):469-71. PubMed ID: 21109997
[No Abstract] [Full Text] [Related]
28. Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants.
Mancioppi V; Pozzi E; Zanetta S; Missineo A; Savastio S; Barbetti F; Mellone S; Giordano M; Rabbone I
Front Endocrinol (Lausanne); 2023; 14():1143736. PubMed ID: 37251668
[TBL] [Abstract][Full Text] [Related]
29. ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.
Sperling MA
N Engl J Med; 2006 Aug; 355(5):507-10. PubMed ID: 16885555
[No Abstract] [Full Text] [Related]
30. Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene.
Tonini G; Bizzarri C; Bonfanti R; Vanelli M; Cerutti F; Faleschini E; Meschi F; Prisco F; Ciacco E; Cappa M; Torelli C; Cauvin V; Tumini S; Iafusco D; Barbetti F;
Diabetologia; 2006 Sep; 49(9):2210-3. PubMed ID: 16816952
[No Abstract] [Full Text] [Related]
31. Mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism.
Gloyn AL; Siddiqui J; Ellard S
Hum Mutat; 2006 Mar; 27(3):220-31. PubMed ID: 16416420
[TBL] [Abstract][Full Text] [Related]
32. KATP channel mutations in infants with permanent diabetes diagnosed after 6 months of life.
Rubio-Cabezas O; Flanagan SE; Damhuis A; Hattersley AT; Ellard S
Pediatr Diabetes; 2012 Jun; 13(4):322-5. PubMed ID: 21981029
[TBL] [Abstract][Full Text] [Related]
33. Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism.
Flanagan SE; Clauin S; Bellanné-Chantelot C; de Lonlay P; Harries LW; Gloyn AL; Ellard S
Hum Mutat; 2009 Feb; 30(2):170-80. PubMed ID: 18767144
[TBL] [Abstract][Full Text] [Related]
34. Mutations in the ABCC8 gene can cause autoantibody-negative insulin-dependent diabetes.
Hartemann-Heurtier A; Simon A; Bellanné-Chantelot C; Reynaud R; Cavé H; Polak M; Vaxillaire M; Grimaldi A
Diabetes Metab; 2009 Jun; 35(3):233-5. PubMed ID: 19342262
[TBL] [Abstract][Full Text] [Related]
35. New insights into K
Pipatpolkai T; Usher S; Stansfeld PJ; Ashcroft FM
Nat Rev Endocrinol; 2020 Jul; 16(7):378-393. PubMed ID: 32376986
[TBL] [Abstract][Full Text] [Related]
36. Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation.
Mak CM; Lee CY; Lam CW; Siu WK; Hung VC; Chan AY
Diagn Mol Pathol; 2012 Mar; 21(1):56-9. PubMed ID: 22306677
[TBL] [Abstract][Full Text] [Related]
37. Successful transition to sulfonylurea therapy in two Iraqi siblings with neonatal diabetes mellitus and iDEND syndrome due to ABCC8 mutation.
Ozsu E; Giri D; Seymen Karabulut G; Senniappan S
J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1403-1406. PubMed ID: 27849623
[TBL] [Abstract][Full Text] [Related]
38. A novel ABCC8 mutation illustrates the variability of the diabetes phenotypes associated with a single mutation.
Klee P; Bellanné-Chantelot C; Depret G; Llano JP; Paget C; Nicolino M
Diabetes Metab; 2012 Apr; 38(2):179-82. PubMed ID: 22326206
[TBL] [Abstract][Full Text] [Related]
39. [Neonatal diabetes: a disease linked to multiple mechanisms].
Flechtner I; Vaxillaire M; Cavé H; Froguel P; Polak M
Arch Pediatr; 2007 Nov; 14(11):1356-65. PubMed ID: 17931842
[TBL] [Abstract][Full Text] [Related]
40. Characterization of ABCC8 and KCNJ11 gene mutations and phenotypes in Korean patients with congenital hyperinsulinism.
Park SE; Flanagan SE; Hussain K; Ellard S; Shin CH; Yang SW
Eur J Endocrinol; 2011 Jun; 164(6):919-26. PubMed ID: 21422196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
